Pasithea Therapeutics KTTA
NASDAQ KTTA
$0.49 0.00 (-0.79%)
At close: Oct 1, 2026 · 4:00 PM EDT

Pasithea Therapeutics (KTTA) Revenue (2022)

Updated

Pasithea Therapeutics (KTTA) reported Revenue of $240,712 for Q4 2022, up 10.1% from the prior quarter.

Analysis

Pasithea Therapeutics (KTTA) Revenue (2022) Analysis & Trends

For FY2022, Pasithea Therapeutics posted Revenue of $486,559.

  • By year, Revenue came in at $15,062 in FY2021.
  • Per Business Quant data, the three quarters before Q4 2022 came in at $218,608 (Q3 2022), $13,581 (Q2 2022) and $13,658 (Q1 2022).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Revenue (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 25.31 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 16.99 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 16.61 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 14.41 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 15.38 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 10.05 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 7.80 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 15.03 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 3.33 Bn
10 Pasithea Therapeutics 16.37 Mn 16.37 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2022 240,712.00
Sep 30, 2022 218,608.00
Jun 30, 2022 13,581.00
Mar 31, 2022 13,658.00
API Access

Pasithea Therapeutics Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=revenue&ticker=KTTA&period=max&api_key=YOUR_API_KEY